Date:2/6/2008

ste. DANONE RESEARCH is the organization responsible for all DANONE R&D activities (900 employees worldwide). Its mission is to formulate DANONE products with health benefits (mainly through probiotics) and the scientific evidence to support the claims for these products. It also studies the effects of food on health and aims to continuously improve the nutritional profile of DANONE products worldwide. Probiotic research is a key expertise of DANONE RESEARCH. Over the past 90 years, DANONE has built the world's most comprehensive collection of lactic bacteria strains sampled directly from bio-diversity. Referred to as the DANONE "culture-collection", it contains approximately 3,000 different lactic bacteria strains. In addition to taste and texture, some of these ferments provide probiotic health properties. Such is the case of the Bifidus DN 173 010 strain, used to produce Activia, and the Lactobacillus casei DN 114 011 strain in DanActive. One hundred of these strains have been thoroughly studied and only 50 are currently being used in DANONE products. Therefore the "culture-collection" holds considerable additional future potential for product innovation. DANONE RESEARCH has made it a key research area, using state-of-the-art technologies such as genomics and robotics to select the probiotic bacteria of the future. For more information, please visit http://www.danone.com/?lang=en, http://www.danone.com/en/research-innovations.html, http://www.dannon.com.

Yakult Honsha Co., Ltd., headquartered in Tokyo, Japan, is the world's pioneer in probiotics by introducing the first single shot probiotics drink, Yakult(R), in 1935. Founded by microbiologist Dr. Minoru Shirota, Yakult(R) contains high amounts of its signature strain, Lactobacillus casei Shirota. Yakult is committed to
'/>"/>

SOURCE Global Probiotics Council Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4
Related biology technology :

1. Global Experts Explore Entire Spectrum of Aids Vaccine Development
2. Mindray to Present at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
3. Advanced Life Sciences to Present at 2007 UBS Global Life Sciences Conference
4. Touching 418 Billion Lives, Hepatitis Still Presents Significant Threat to Global Health
5. Touching 418 Million Lives, Hepatitis Still Presents Significant Threat to Global Health
6. Clinsys Clinical Research, Inc. Announces Key Hires, Rajagopalan Srinivasan, Ph.D, to Strengthen Global Biostatistics Service Offering and Christopher Gregory, Ph.D, to Scientific Affairs
7. Jazz Pharmaceuticals to Present at UBS Global Life Sciences Conference
8. A Large-Scale Research Project by a Dutch Consortium Addressing a Global Problem
9. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech 2007 Conference
10. Allos Therapeutics to Present at the 2007 UBS Global Life Sciences Conference
11. Merrill Lynch Global Pharmaceutical, Biotech and Medtech Conference to Webcast Millennium Presentation